Clinical Trial Update: Registry for Pulmonary Hypertension Due to Left Heart Disease in China

View source ↗

Summary

A Chinese clinical trial registry update documents a registry study on pulmonary hypertension caused by left heart disease, sponsored by the Chinese Academy of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Due to Left Heart Disease

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Pulmonary Hypertension Due to Left Heart Disease | Status: UNKNOWN